Burrill & Company is a financial services firm focused on the life sciences industry based in San Francisco. It has principal activities in private equity, venture capital, merchant banking, and media. It invests in industrial and agricultural biotechnology, pharmaceuticals, health care, and medical technology companies.
G. Steven Burrill founded Burrill & Company in 1994. Its portfolio includes MUX Greenlight Biosciences, Neurotech Pharmaceuticals, Neos Therapeutics, Cobalt Technologies, Nora Therapeutics, BetterDoctor, Catalyst Biosciences, Strand Life Sciences, Odyssey Thera, MabVax Therapeutics, CareDx, Gevo, diaDexus, Virdia, Alexza Pharmaceuticals, and Endocyte.
A renewable chemicals and advanced biofuels company.
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
AliveCor is a San Francisco-based company making a clinical grade electrocardiogram (ECG) recorder that was founded in 2010 by Bruce Satchwell, David Albert, and Kim Barnett.
A biotechnology company developing products for the treatment of cancer
G. Steven Burrill
Founder and CEO